Stephen PAKOLA

Person

Irvington, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of mucopolysaccharidosis II with recombinant human iduron...
- Patent number 11,986,515
- Issue date May 21, 2024
- REGENXBIO Inc.
- Stephen Joseph Pakola
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240117328
- Publication date Apr 11, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240058426
- Publication date Feb 22, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS FORMULATIONS...
- Publication number 20230372538
- Publication date Nov 23, 2023
- Regenxbio Inc.
- Jared Bee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE
- Publication number 20230364206
- Publication date Nov 16, 2023
- Regenxbio Inc.
- Christina Maria Ohnsman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20230088992
- Publication date Mar 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...
- Publication number 20230059395
- Publication date Feb 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DIABETIC RETINOPATHY WITH FULLY-HUMAN POST-TRANSLATION...
- Publication number 20220280608
- Publication date Sep 8, 2022
- Regenxbio Inc.
- Stephen Joseph Pakola
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DIABETIC NEPHROPATHY USING HPTPB INHIBITORS
- Publication number 20190262321
- Publication date Aug 29, 2019
- AERPIO THERAPEUTICS, INC.
- Kevin PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stephen PAKOLA

Person

Patents Grantslast 30 patents

Treatment of mucopolysaccharidosis II with recombinant human iduron...

Patents Applicationslast 30 patents

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS FORMULATIONS...

GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...

TREATMENT OF DIABETIC RETINOPATHY WITH FULLY-HUMAN POST-TRANSLATION...

METHODS OF TREATING DIABETIC NEPHROPATHY USING HPTPB INHIBITORS